about
Lack of association between measles virus vaccine and autism with enteropathy: a case-control studyPotential role of miR-9 and miR-223 in recurrent ovarian cancerPotential viral pathogenic mechanism for new variant inflammatory bowel diseaseMolecular pathology of prostate cancerReal-time quantitative analysis of E-cadherin expression in ret/PTC-1-activated thyroid neoplasms.Real-time analysis of beta- and gamma-catenin mRNA expression in ret/PTC-1 activated and nonactivated thyroid tissues.Ret/PTC chimeric transcripts in an Irish cohort of sporadic papillary thyroid carcinoma.Distinct array comparative genomic hybridization profiles in oral squamous cell carcinoma occurring in young patients.Low-level genomic instability is a feature of papillary thyroid carcinoma: an array comparative genomic hybridization study of laser capture microdissected papillary thyroid carcinoma tumors and clonal cell lines.Comparison of miRNA expression patterns using total RNA extracted from matched samples of formalin-fixed paraffin-embedded (FFPE) cells and snap frozen cells.A molecular expression signature distinguishing follicular lesions in thyroid carcinoma using preamplification RT-PCR in archival samples.Improved RNA quality and TaqMan Pre-amplification method (PreAmp) to enhance expression analysis from formalin fixed paraffin embedded (FFPE) materials.Regulation of microRNA biosynthesis and expression in 2102Ep embryonal carcinoma stem cells is mirrored in ovarian serous adenocarcinoma patients.Evaluation of Zinc-α-2-Glycoprotein and Proteasome Subunit β-Type 6 Expression in Prostate Cancer Using Tissue Microarray Technology.The MyD88+ phenotype is an adverse prognostic factor in epithelial ovarian cancer.Cellular localisation of HHV-8 in Castleman's disease: is there a link with lymph node vascularity?Inkjet-like printing of single-cells.All azoospermic males should be screened for cystic fibrosis mutations before intracytoplasmic sperm injection.Platelet adhesion and degranulation induce pro-survival and pro-angiogenic signalling in ovarian cancer cells.The role of secreted frizzled-related protein 2 expression in prostate cancer.An integrated analysis of the SOX2 microRNA response program in human pluripotent and nullipotent stem cell lines.MIR141 Expression Differentiates Hashimoto Thyroiditis from PTC and Benign Thyrocytes in Irish Archival Thyroid Tissues.Activated eosinophils in association with enteric nerves in inflammatory bowel disease.Potentially important microRNA cluster on chromosome 17p13.1 in primary peritoneal carcinoma.FOXA1 is a potential oncogene in anaplastic thyroid carcinoma.Development of a semi-conductor sequencing-based panel for genotyping of colon and lung cancer by the Onconetwork consortiump16INK4A as a marker for cervical dyskaryosis: CIN and cGIN in cervical biopsies and ThinPrep smears.p16INK4A, CDC6, and MCM5: predictive biomarkers in cervical preinvasive neoplasia and cervical cancer.Identifying novel hypoxia-associated markers of chemoresistance in ovarian cancer.Aspirin and P2Y12 inhibition attenuate platelet-induced ovarian cancer cell invasion.Topoisomerase II-alpha expression increases with increasing Gleason score and with hormone insensitivity in prostate carcinoma.Suppression of cancer stemness p21-regulating mRNA and microRNA signatures in recurrent ovarian cancer patient samples.Molecular classification and biomarker discovery in papillary thyroid carcinoma.An integrative model for recurrence in ovarian cancer.Low MAD2 expression levels associate with reduced progression-free survival in patients with high-grade serous epithelial ovarian cancerAltered expression of mir-222 and mir-25 influences diverse gene expression changes in transformed normal and anaplastic thyroid cells, and impacts on MEK and TRAIL protein expression.HPV vaccine acceptability in HIV-infected and HIV negative men who have sex with men (MSM) in Ireland.BRAFV600E: implications for carcinogenesis and molecular therapy.RET protein expression in papillary renal cell carcinoma.Assessment of ret/PTC-1 rearrangements in neoplastic thyroid tissue using TaqMan RT-PCR.
P50
Q21144239-DD23538E-E03B-465C-9971-B3EF39EC71D5Q21245724-BD6409B7-C4EF-4550-AA63-595E8BFE6408Q24535473-94BD26AC-5F6D-47BD-B14E-F63732CE977CQ24672410-A0E803CE-6E12-418A-BEF4-9D13B59601A6Q30885720-4971EF95-0DDC-46F4-97E0-F2D1996E992EQ31133084-0D63C01F-35E5-4641-A0B1-CA4EDCEA3344Q33185987-562199E1-E914-448D-AF27-5DEE7877EA2EQ33233632-C7D1D57B-4A39-4587-A141-2B26BC74C79EQ33269396-7F461AB8-DD67-4D63-83F9-D75D4B2618ADQ33289523-9A0C4217-65C4-40D2-B3F1-A5A24AD4B901Q33292141-5DCA44B6-79DA-4668-92D6-10732D873A8EQ33318568-7F226507-2329-4B7D-A529-12449F6507E2Q33587316-64E15D86-E91E-4A97-9A47-D87A7EC79993Q33641205-17D1880C-2958-4730-AC9F-197668C296DBQ33825555-95A20E31-0ED4-4489-BC62-B6010674A1C5Q33918443-9CBB615A-5D40-4B23-A8AB-F265D5D8F4A5Q33927509-AB1AE725-B479-4B33-B39C-F1BFB0F34B4DQ34022016-34F5801E-1299-4B4E-BEB8-AB815E20809EQ34056033-4072AA03-2AC3-4774-AA94-7B8DA4F9E240Q34103775-B441D7AF-FC23-4E8E-8AE8-CFA0FEC1DEF3Q34174419-827650AD-7000-4366-BAC8-95427156E076Q34411905-0A63A0E6-4712-482C-800D-3FF2F99A8D9AQ34745442-3FE9E813-13D8-40E7-AC28-1979A6286ADCQ34803840-29DECE9F-2445-489C-9065-91A80DE4C1E3Q34983133-A7766315-8F8D-4114-9C18-E2E2CB3FF4A1Q35053271-331EE3A4-61C8-438C-91E0-AE1E7E2E8C29Q35586592-27EC14DC-038F-466A-9577-9F61FB163C36Q35588555-E4BA905C-B4AB-4AB7-8660-541831D38F9CQ35709343-B4283892-B76F-4D62-9FA6-4F6A18E1C392Q35768450-59ABB240-CD7B-4C6A-ABD6-6D3A8172DE7CQ35770181-D8357290-162D-4BF1-8A52-6196FE18F81DQ35772988-B2A064D6-DE15-4755-9572-5BA26FC0A88FQ36299916-43818520-EC70-499E-A7C7-6DDF7B552359Q36470173-C815A71F-7B88-4F5E-95D8-9E8E4CCBFED3Q36670959-C29EBE06-C6B5-44D8-B038-7B52C08BC363Q37071712-F2158DA3-23B7-4CC7-A0E0-1C6C705AC0A9Q37135212-FB843775-C273-4070-B3E7-E01B9251BB59Q37851238-F9264571-B657-4062-9FC3-B3A097D6670AQ38411398-800D7F3A-1A3E-431C-83A7-9C317CC6ECA8Q38464128-01A5C59D-5EDC-4657-AFA9-E27C49C0D6C2
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Orla Sheils
@ast
Orla Sheils
@en
Orla Sheils
@es
Orla Sheils
@fr
Orla Sheils
@nl
Orla Sheils
@sl
type
label
Orla Sheils
@ast
Orla Sheils
@en
Orla Sheils
@es
Orla Sheils
@fr
Orla Sheils
@nl
Orla Sheils
@sl
prefLabel
Orla Sheils
@ast
Orla Sheils
@en
Orla Sheils
@es
Orla Sheils
@fr
Orla Sheils
@nl
Orla Sheils
@sl
P1053
B-8461-2015
P106
P1153
6701770039
P21
P31
P3829
P496
0000-0002-4493-9496